The cytokine TSLP has been shown to be a key factor in maintaining immune homeostasis and regulating inflammatory responses at mucosal barriers. While the role of TSLP in type 2 immune responses has ...
The 1980s and 1990s were the golden years for the discovery of cytokines by academic institutions and biotech companies 1. Before the availability of the human genome sequence, the starting point was ...
The PROXIMA 2 beamline at Synchrotron SOLEIL recently celebrated its first birthday. It's an occasion to reflect back upon a year of the collaborative work accomplished and its high scientific impact.
Dublin, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The "TSLP Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This product provides basic information on approved drugs and drug ...
Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "TSLP Inhibitors and TSLP Receptor Antagonists: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...
PHILADELPHIA – Treating obese mice with the cytokine known as TSLP led to significant abdominal fat and weight loss compared to controls, according to new research published Thursday in Science from ...
Hosted on MSN
Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting
Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in. On September 30, Upstream Bio presented new structural and mechanistic data for its therapeutic candidate, verekitug, at the ...
With a $165 million cash tailwind, Windward Bio is advancing its TSLP challengers to Amgen and AstraZeneca's Tezspire. (valio84sl/iStock/Getty Images Plus) Windward Bio is in full sail with a $165 ...
Generate Biomedicines Inc. proved that enthusiasm hasn’t waned for TSLP as a target by pricing an IPO selling 25 million shares at $16 each for proceeds of $400 million. Generate’s lead compound is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results